CONTRAINDICATIONS History of hypersensitivity reaction to tirzepatide or any of its excipients Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) PRECAUTIONS Kidney disease No dose adjustment is recommended in patients with any degree of renal impairment Liver disease No dose adjustment is recommended in patients with any degree of liver disease Stomach disorders Tirzepatide slows gastric emptying and is not recommended in patients with significant stomach disorders, including diabetic gastroparesis General anesthesia or deep sedation GLP-1 therapies, like tirzepatide, slow gastric emptying, possibly increasing the risk of residual gastric contents and pulmonary aspiration in patients receiving anesthesia or deep sedation for procedures
The no-DAC variant, with a reported half-life of around 30 minutes, is studied where a shorter-acting profile is required for the experimental design
Seeking answers and help, she turned to Evan Blum, MD, a physician and co-founder and medical director of The Aesthetic Concierge, who introduced the concept of microdosing GLP-1 medications to get the benefits of these medications without the sole focus being on weight management
Curr Opin Crit Care
A reference tissue atlas for the human kidney
Our highly skilled master nurse injectors understand that weight loss can be a long, tedious process, which is why were offering an innovative treatment plan for your goals